Theralase Technologies Inc. V.TLT

Alternate Symbol(s): TLTFF

Healthcare Medical Devices

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called Photo Dynamic Compounds (PDCs) and activates them with patent pending laser technology to destroy specifically targeted cancers, bacteria and viruses. The CLT division is responsible for the Company’s medical laser business. The Cool Laser Therapy division designs, develops, manufactures and markets super-pulsed laser technology indicated for the healing of chronic knee pain. The technology has been used off-label for healing numerous nerve, muscle and joint conditions. The Company develops products both internally and using the assistance of specialist external resources.

TSXV:TLT - Post by User

Theralase Technologies Inc.

Bullboard Posts

Comment by Hankerchiefon Sep 28, 2018 9:03am

68 Views

Post# 28707820

RE:RE:RE:Reversing the Warburg Effect is a very big deal

"The advantages of Rutherrin over TLD-1433 are significant.It can be administered intravenously (and will pass through the blood/brain barrier) and can be activated over a wider spectrum of wavelengths giving a potential to treat non-superficial tumours."

Fred,
Do we know if any humans have yet had Rutherrin given intravenously? If it has been done and there are no side effects then this could be huge.

Bullboard Posts

Sirios Resource discovers visible gold in Quebec